학술논문
Invalidity of Tokyo guidelines in acute biliary pancreatitis: A multicenter cohort analysis of 944 pancreatitis cases
Document Type
Clinical report
Author
Juhász, Márk Félix; Tóháti, Rebeka; Jászai, Viktória Adrienn; Molnár, Regina; Farkas, Nelli; Czakó, László; Vincze, Áron; Erőss, Bálint; Szentesi, Andrea; Izbéki, Ferenc; Papp, Mária; Hegyi, Péter; Párniczky, Andrea; Váncsa, Szilárd; Márta, Katalin; Földi, Mária; Nagy, Rita; Hegyi, Péter Jenő; Ocskay, Klementina; Imrei, Marcell; Mikó, Alexandra; Gódi, Szilárd; Bajor, Judit; Hágendorn, Roland; Sarlós, Patrícia; Szabó, Imre; Czimmer, József; Faluhelyi, Nándor; Kanizsai, Péter; Nagy, Tamás; Gajdán, László; Kui, Balázs; Illés, Dóra; Takács, Tamás; Vitális, Zsuzsanna; Hamvas, József; Varga, Márta; Bod, Barnabás; Novák, János; Maurovich‐Horváth, Pál; Doros, Attila; Deák, Pál Ákos; Varga, Csaba; Gaál, Szabolcs; Zubek, László; Gál, János; Lázár, Balázs; Hussein, Tamás; Kovács, Bea; Tarján, Dorottya; Lipp, Mónika; Urbán, Orsolya; Tornai, Tamás
Source
United European Gastroenterology Journal. October 2023, Vol. 11 Issue 8, p767, 8 p.
Subject
Language
English
Abstract
Key summary The established knowledge on this subject * Biliary pancreatitis is mostly (around 80% of cases) caused by spontaneously passing stones. * Less frequently, biliary obstruction can also lead [...]
: Background: There is a noteworthy overlap between the clinical picture of biliary acute pancreatitis (AP) and the 2018 Tokyo guidelines currently used for the diagnosis of cholangitis (AC) and cholecystitis (CC). This can lead to significant antibiotic and endoscopic retrograde cholangiopancreatography (ERCP) overuse. Objectives: We aimed to assess the on‐admission prevalence of AC/CC according to the 2018 Tokyo guidelines (TG18) in a cohort of biliary AP patients, and its association with antibiotic use, ERCP and clinically relevant endpoints. Methods: We conducted a secondary analysis of the Hungarian Pancreatic Study Group's prospective multicenter registry of 2195 AP cases. We grouped and compared biliary cases (n = 944) based on the on‐admission fulfillment of definite AC/CC according to TG18. Aside from antibiotic use, we evaluated mortality, AC/CC/AP severity, ERCP performance and length of hospitalization. We also conducted a literature review discussing each criteria of the TG18 in the context of AP. Results: 27.8% of biliary AP cases fulfilled TG18 for both AC and CC, 22.5% for CC only and 20.8% for AC only. Antibiotic use was high (77.4%). About 2/3 of the AC/CC cases were mild, around 10% severe. Mortality was below 1% in mild and moderate AC/CC patients, but considerably higher in severe cases (12.8% and 21.2% in AC and CC). ERCP was performed in 89.3% of AC cases, common bile duct stones were found in 41.1%. Conclusion: Around 70% of biliary AP patients fulfilled the TG18 for AC/CC, associated with a high rate of antibiotic use. Mortality in presumed mild or moderate AC/CC is low. Each of the laboratory and clinical criteria are commonly fulfilled in biliary AP, single imaging findings are also unspecific—AP specific diagnostic criteria are needed, as the prevalence of AC/CC are likely greatly overestimated. Randomized trials testing antibiotic use are also warranted.
: Background: There is a noteworthy overlap between the clinical picture of biliary acute pancreatitis (AP) and the 2018 Tokyo guidelines currently used for the diagnosis of cholangitis (AC) and cholecystitis (CC). This can lead to significant antibiotic and endoscopic retrograde cholangiopancreatography (ERCP) overuse. Objectives: We aimed to assess the on‐admission prevalence of AC/CC according to the 2018 Tokyo guidelines (TG18) in a cohort of biliary AP patients, and its association with antibiotic use, ERCP and clinically relevant endpoints. Methods: We conducted a secondary analysis of the Hungarian Pancreatic Study Group's prospective multicenter registry of 2195 AP cases. We grouped and compared biliary cases (n = 944) based on the on‐admission fulfillment of definite AC/CC according to TG18. Aside from antibiotic use, we evaluated mortality, AC/CC/AP severity, ERCP performance and length of hospitalization. We also conducted a literature review discussing each criteria of the TG18 in the context of AP. Results: 27.8% of biliary AP cases fulfilled TG18 for both AC and CC, 22.5% for CC only and 20.8% for AC only. Antibiotic use was high (77.4%). About 2/3 of the AC/CC cases were mild, around 10% severe. Mortality was below 1% in mild and moderate AC/CC patients, but considerably higher in severe cases (12.8% and 21.2% in AC and CC). ERCP was performed in 89.3% of AC cases, common bile duct stones were found in 41.1%. Conclusion: Around 70% of biliary AP patients fulfilled the TG18 for AC/CC, associated with a high rate of antibiotic use. Mortality in presumed mild or moderate AC/CC is low. Each of the laboratory and clinical criteria are commonly fulfilled in biliary AP, single imaging findings are also unspecific—AP specific diagnostic criteria are needed, as the prevalence of AC/CC are likely greatly overestimated. Randomized trials testing antibiotic use are also warranted.